Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 17 · 3 feeds behind: Executive-branch trades, 7 days, and 2 more · Every feed →

All 32Congress 0Executive branch 0Insiders 32
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

DNTH · $50K+ · 32 trades

Trades
32
Buys 0 · Sells 32
People
7
Stocks
1
Disclosed value
$31.6M
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLEdward Carr Chief Accounting OfficerDNTH Dianthus Therapeutics, Inc.$358Kdisclosed Sep 18 · filed 1 day after the trade
  2. ▼ SELLEdward Carr Chief Accounting OfficerDNTH Dianthus Therapeutics, Inc.$73.1Kdisclosed Sep 18 · filed 1 day after the trade
  3. ▼ SELLEdward Carr Chief Accounting OfficerDNTH Dianthus Therapeutics, Inc.$114Kdisclosed Sep 18 · filed 1 day after the trade
  4. ▼ SELLEdward Carr Chief Accounting OfficerDNTH Dianthus Therapeutics, Inc.$686Kdisclosed Sep 18 · filed 1 day after the trade
  5. ▼ SELLEdward Carr Chief Accounting OfficerDNTH Dianthus Therapeutics, Inc.$796Kdisclosed Sep 18 · filed 1 day after the trade
  6. ▼ SELLSimrat Randhawa EVP, Head of R&DDNTH Dianthus Therapeutics, Inc.$1.4Mdisclosed Sep 3 · filed 2 days after the trade
  7. ▼ SELLSimrat Randhawa EVP, Head of R&DDNTH Dianthus Therapeutics, Inc.$767Kdisclosed Sep 3 · filed 2 days after the trade
  8. ▼ SELLSimrat Randhawa EVP, Head of R&DDNTH Dianthus Therapeutics, Inc.$273Kdisclosed Sep 3 · filed 2 days after the trade
  9. ▼ SELLSimon Read DirectorDNTH Dianthus Therapeutics, Inc.$327Kdisclosed Aug 19 · filed the same day
  10. ▼ SELLAnne McGeorge DirectorDNTH Dianthus Therapeutics, Inc.$156Kdisclosed Aug 11 · filed 1 day after the trade
  11. ▼ SELLSimon Read DirectorDNTH Dianthus Therapeutics, Inc.$52.2Kdisclosed Aug 11 · filed 1 day after the trade
  12. ▼ SELLSimon Read DirectorDNTH Dianthus Therapeutics, Inc.$79.7Kdisclosed Aug 11 · filed 1 day after the trade
  13. ▼ SELLAdam M Veness SVP, General Counsel and Sec.DNTH Dianthus Therapeutics, Inc.$356Kdisclosed Aug 11 · filed 4 days after the trade
  14. ▼ SELLAdam M Veness SVP, General Counsel and Sec.DNTH Dianthus Therapeutics, Inc.$68.5Kdisclosed Aug 11 · filed 4 days after the trade
  15. ▼ SELLAnne McGeorge DirectorDNTH Dianthus Therapeutics, Inc.$78Kdisclosed Aug 11 · filed 1 day after the trade
  16. ▼ SELLAnne McGeorge DirectorDNTH Dianthus Therapeutics, Inc.$111Kdisclosed Aug 11 · filed 1 day after the trade
  17. ▼ SELLAnne McGeorge DirectorDNTH Dianthus Therapeutics, Inc.$197Kdisclosed Aug 11 · filed 1 day after the trade
  18. ▼ SELLSimon Read DirectorDNTH Dianthus Therapeutics, Inc.$90.5Kdisclosed Aug 11 · filed 1 day after the trade
  19. ▼ SELLAdam M Veness SVP, General Counsel and Sec.DNTH Dianthus Therapeutics, Inc.$1.8Mdisclosed Aug 11 · filed 1 day after the trade
  20. ▼ SELLAnne McGeorge DirectorDNTH Dianthus Therapeutics, Inc.$303Kdisclosed Aug 11 · filed 1 day after the trade
  21. ▼ SELLMarino Garcia CEO and PresidentDNTH Dianthus Therapeutics, Inc.$1.1Mdisclosed Aug 7 · filed the same day
  22. ▼ SELLMarino Garcia CEO and PresidentDNTH Dianthus Therapeutics, Inc.$88.6Kdisclosed Aug 7 · filed the same day
  23. ▼ SELLMarino Garcia CEO and PresidentDNTH Dianthus Therapeutics, Inc.$2.4Mdisclosed Aug 7 · filed the same day
  24. ▼ SELLMarino Garcia CEO and PresidentDNTH Dianthus Therapeutics, Inc.$2.6Mdisclosed Aug 7 · filed the same day
  25. ▼ SELLMarino Garcia CEO and PresidentDNTH Dianthus Therapeutics, Inc.$11.2Mdisclosed Aug 7 · filed the same day